E. Abad et al., RELATIONSHIP BETWEEN ANCA AND CLINICAL ACTIVITY IN INFLAMMATORY BOWEL-DISEASE - VARIATION IN PREVALENCE OF ANCA AND EVIDENCE OF HETEROGENEITY, Journal of autoimmunity, 10(2), 1997, pp. 175-180
Antineutrophil cytoplasmic antibodes (ANCA) are markers of necrotizing
vasculitis. ANCA have been recently detected in the two forms of infl
ammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn's dise
ase (CD). To assess the possible role of ANCA in the diagnosis and man
agement of IBD we studied the prevalence of ANCA at diagnosis and duri
ng follow-up in a group of 89 IBD patients. The relationship between A
NCA and clinical features of IBD was investigated. ANCA assayed by ind
irect immunofluorescence were detected in 38/52 (73%) of the UC patien
ts but only 6/37 (16.6%) of the CD patients (P<0.005) and in none of t
he controls. In the UC group, but not in the CD group, there was a pos
itive correlation between ANCA and disease activity. The sensitivity a
nd specificity of ANCA for the diagnosis of UC were 73 and 83.7% respe
ctively. The most commonly observed pattern of ANCA in IBD patients wa
s perinuclear: in 84% of the UC and 66.6% of the CD patients positive
for ANCA, respectively. However, careful comparison of IFL patterns re
vealed some distinct features of IBD-associated ANCA when compared to
vasculitis-associated ANCA. In addition, most ANCA positive sera from
IBD patients were negative for antibodies to proteinase 3 and myeloper
oxidase by ELISA. These results suggest that the autoantigens recogniz
ed by ANCA are different in patients with IBD from those with necrotis
ing vasculitis. (C) 1997 Academic Press Limited.